Source: International Congress 2019 – New trends in the management of pulmonary vascular disease
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Sanchez (Paris, France). Cancer-associated thrombosis. International Congress 2019 – New trends in the management of pulmonary vascular disease

Member's Comments

No comment yet.

Related content which might interest you: Cancer-associated thrombosis: the when, how and why Source: Eur Respir Rev, 28 (151) 180119; 10.1183/16000617.0119-2018 Year: 2019 Treatment and prevention of cancer-associated venous thromboembolism Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management Year: 2021 Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Cerebral venous thrombosis in Covid-19 Source: Virtual Congress 2021 – Biological and functional markers of COVID-19 Year: 2021 Risk of deep vein thrombosis and pulmonary embolism in asthma Source: Eur Respir J 2013; 42: 655-661 Year: 2013 Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis? Source: Eur Respir J 2016; 47: 369-373 Year: 2016 Unusual site thrombosis: splanchnic vein thrombosis, management in noncirrothic Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Clinical significance of deep venous thrombosis in symptomatic pulmonary embolism Source: International Congress 2017 – Pulmonary embolism Year: 2017 Deep venous thrombosis associated with pulmonary tuberculosis Source: Annual Congress 2007 - Difficult tuberculosis cases I Year: 2007 Prognostic significance of asymptomatic pulmonary embolism in patients with deep vein thrombosis Source: Eur Respir J 2004; 24: Suppl. 48, 685s Year: 2004 Chronic thromboembolic pulmonary hypertension: update 2004 Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=243 Year: 2004 Genetic and acquired risk factors of venous thromboembolism Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=1 Year: 2004 Fibrinogen AaThr312Ala polymorphism predisposes to chronic thromboembolic pulmonary hypertension Source: Annual Congress 2007 - Acute and chronic pulmonary embolism Year: 2007 Persistent lung perfusion defect is a risk factor for recurrent venous thromboembolism after pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Bilateral chylothorax in a patient with chronic central vein thrombosis and chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension? Source: Eur Respir J 2015; 46: 1214-1217 Year: 2015 The genetic polymorphisms associated with acute pulmonary embolism (PE) and deep venous thrombosis (DVT) Source: Eur Respir J 2001; 18: Suppl. 33, 381s Year: 2001 Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Incidence of recurrent thromboembolism and chronic thromboembolic pulmonary hypertension after pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011